CN102256930B - 作为抗痤疮剂的多不饱和脂肪酸及二醇酯 - Google Patents

作为抗痤疮剂的多不饱和脂肪酸及二醇酯 Download PDF

Info

Publication number
CN102256930B
CN102256930B CN200980151867.4A CN200980151867A CN102256930B CN 102256930 B CN102256930 B CN 102256930B CN 200980151867 A CN200980151867 A CN 200980151867A CN 102256930 B CN102256930 B CN 102256930B
Authority
CN
China
Prior art keywords
acid
polyunsaturated fatty
compounds
omega
coupling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN200980151867.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN102256930A (zh
Inventor
D·勒杜莱斯
S·多纳斯-马里诺
M-F·阿里耶斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Dermo Cosmetique SA
Original Assignee
Pierre Fabre Dermo Cosmetique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40875013&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102256930(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pierre Fabre Dermo Cosmetique SA filed Critical Pierre Fabre Dermo Cosmetique SA
Publication of CN102256930A publication Critical patent/CN102256930A/zh
Application granted granted Critical
Publication of CN102256930B publication Critical patent/CN102256930B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN200980151867.4A 2008-12-22 2009-12-21 作为抗痤疮剂的多不饱和脂肪酸及二醇酯 Active CN102256930B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0858967 2008-12-22
FR0858967A FR2940281B1 (fr) 2008-12-22 2008-12-22 Ester de diol et d'acide gras polyinsature comme agent anti-acne
PCT/EP2009/067701 WO2010072738A1 (fr) 2008-12-22 2009-12-21 Ester de diol et d'acide gras polyinsature comme agent anti-acne

Publications (2)

Publication Number Publication Date
CN102256930A CN102256930A (zh) 2011-11-23
CN102256930B true CN102256930B (zh) 2014-03-12

Family

ID=40875013

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200980151867.4A Active CN102256930B (zh) 2008-12-22 2009-12-21 作为抗痤疮剂的多不饱和脂肪酸及二醇酯

Country Status (26)

Country Link
US (1) US8623916B2 (enExample)
EP (1) EP2379484B1 (enExample)
JP (1) JP5587333B2 (enExample)
KR (1) KR101676055B1 (enExample)
CN (1) CN102256930B (enExample)
AU (1) AU2009331526B2 (enExample)
BR (1) BRPI0923494B1 (enExample)
CA (1) CA2747681C (enExample)
CL (1) CL2011001539A1 (enExample)
CO (1) CO6390033A2 (enExample)
ES (1) ES2424088T3 (enExample)
FR (1) FR2940281B1 (enExample)
GE (1) GEP20135820B (enExample)
IL (1) IL213646A (enExample)
MA (1) MA32810B1 (enExample)
MX (1) MX2011006659A (enExample)
MY (1) MY151002A (enExample)
NZ (1) NZ593781A (enExample)
PL (1) PL2379484T3 (enExample)
PT (1) PT2379484E (enExample)
RU (1) RU2524779C2 (enExample)
SG (1) SG172342A1 (enExample)
TN (1) TN2011000237A1 (enExample)
UA (1) UA103645C2 (enExample)
WO (1) WO2010072738A1 (enExample)
ZA (1) ZA201103509B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6336902B2 (ja) * 2011-06-22 2018-06-06 ビョーメ バイオサイエンシズ ピーブイティー．リミテッド コンジュゲートベースの抗真菌性および抗菌性プロドラッグ
FR2983858B1 (fr) * 2011-12-08 2014-01-03 Fabre Pierre Dermo Cosmetique Nouveaux composes inhibiteurs de la lipogenese
CA2920457A1 (en) * 2013-08-08 2015-02-12 Galderm Therapeutics Ltd. Anti-acne compositions comprising bile acid-fatty acid conjugates
FR3033135B1 (fr) * 2015-02-27 2018-03-16 Pierre Fabre Dermo-Cosmetique Association d'un retinoide et d'un ester de diol et d'acide gras polyinsature
FR3053253B1 (fr) * 2016-07-01 2020-01-17 Pierre Fabre Dermo-Cosmetique Nouvel extrait d'akenes de silybum marianum et ses utilisations en dermatologie et dermo-cosmetique

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1105016A (zh) * 1993-01-27 1995-07-12 斯科舍集团有限公司 甘油三酯
WO1998013330A1 (en) * 1996-09-26 1998-04-02 Scotia Holdings Plc Esters of unsaturated fatty acids
WO2001038288A1 (en) * 1999-11-24 2001-05-31 Croda International Plc Nervonic acid derivatives, their preparation and use
WO2006019186A1 (en) * 2004-08-18 2006-02-23 Suntory Limited Skin care products, as well as foods and beverages containing 6-o-pufa ascorbic esters

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5534762B2 (enExample) 1975-02-07 1980-09-09
DE4240674C2 (de) 1992-11-26 1999-06-24 Schuelke & Mayr Gmbh Desodorierende Wirkstoffe
MY118354A (en) 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
JPH09110818A (ja) * 1995-10-16 1997-04-28 Sanshin Chem Ind Co Ltd １−エチル−３−（３−ジメチルアミノプロピル）カルボジイミド塩酸塩の製造方法
ES2176692T3 (es) 1996-02-21 2002-12-01 Stoa Sa Composiciones cosmeticas, dermofarmaceuticas o veterinarias para el tratamiento aseptico de la piel humana o animal.
GB9622636D0 (en) 1996-10-30 1997-01-08 Scotia Holdings Plc Presentation of bioactives
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
WO2001001980A1 (en) * 1999-07-06 2001-01-11 The Regents Of The University Of California Methods for the amelioration of neuropsychiatric disorders by inhibiting the inactivating transport of endogenous cannabinoid substances
ES2208498T3 (es) 2001-06-22 2004-06-16 SYMRISE GMBH & CO. KG Uso de 1,2-decanodiol contra germenes causantes de olores corporales desagradables.
US20070265352A1 (en) 2002-02-19 2007-11-15 Joachim Roeding Synergistic mixtures of at least one 1,2 alkanediol such as 1,2-hexanediol and 1,2-octanediol with a further compound having antimicrobial properties
DE10206759A1 (de) 2002-02-19 2003-08-28 Dragoco Gerberding Co Ag Synergistische Mischungen von 1,2-Alkandiolen
SE0301862D0 (sv) 2003-06-26 2003-06-26 Jan Faergeman Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
DE102004031210A1 (de) * 2004-06-28 2006-02-09 Trommsdorff Gmbh & Co. Kg MLV-Kosmetikum
DE10341179A1 (de) 2003-09-06 2005-03-31 Beiersdorf Ag Wirkstoffkombination gegen Akne
US7935732B2 (en) 2004-04-08 2011-05-03 Isp Investments Inc. Antimicrobial compositions
ES2352744T3 (es) * 2004-04-27 2011-02-22 Akzo Nobel Coatings International Bv Pintura pigmentada que se desprende a tiras.
DE102006044849A1 (de) * 2006-09-22 2008-04-03 Symrise Gmbh & Co. Kg Dekonjugierte Alkadiensäureester als Riech- und/oder Aromastoffe

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1105016A (zh) * 1993-01-27 1995-07-12 斯科舍集团有限公司 甘油三酯
WO1998013330A1 (en) * 1996-09-26 1998-04-02 Scotia Holdings Plc Esters of unsaturated fatty acids
WO2001038288A1 (en) * 1999-11-24 2001-05-31 Croda International Plc Nervonic acid derivatives, their preparation and use
WO2006019186A1 (en) * 2004-08-18 2006-02-23 Suntory Limited Skin care products, as well as foods and beverages containing 6-o-pufa ascorbic esters

Also Published As

Publication number Publication date
FR2940281B1 (fr) 2011-04-01
RU2524779C2 (ru) 2014-08-10
UA103645C2 (uk) 2013-11-11
CA2747681A1 (fr) 2010-07-01
EP2379484B1 (fr) 2013-05-29
ES2424088T3 (es) 2013-09-27
JP5587333B2 (ja) 2014-09-10
FR2940281A1 (fr) 2010-06-25
ZA201103509B (en) 2012-01-25
TN2011000237A1 (fr) 2012-12-17
IL213646A0 (en) 2011-07-31
SG172342A1 (en) 2011-07-28
KR20110101152A (ko) 2011-09-15
IL213646A (en) 2014-03-31
CO6390033A2 (es) 2012-02-29
WO2010072738A1 (fr) 2010-07-01
BRPI0923494A2 (pt) 2016-01-26
PT2379484E (pt) 2013-08-22
CA2747681C (fr) 2017-05-16
RU2011128264A (ru) 2013-01-27
MY151002A (en) 2014-03-31
GEP20135820B (en) 2013-05-10
HK1163655A1 (en) 2012-09-14
MA32810B1 (fr) 2011-11-01
KR101676055B1 (ko) 2016-11-14
NZ593781A (en) 2013-02-22
JP2012513380A (ja) 2012-06-14
PL2379484T3 (pl) 2013-10-31
CN102256930A (zh) 2011-11-23
US8623916B2 (en) 2014-01-07
BRPI0923494B1 (pt) 2017-04-18
AU2009331526A1 (en) 2010-07-01
AU2009331526B2 (en) 2013-10-24
EP2379484A1 (fr) 2011-10-26
US20110230557A1 (en) 2011-09-22
MX2011006659A (es) 2011-07-12
CL2011001539A1 (es) 2011-10-14

Similar Documents

Publication Publication Date Title
Norris et al. Resolvin D3 multi-level proresolving actions are host protective during infection
KR101438177B1 (ko) 페록시솜 증식자-활성화 수용체의 활성자 또는 조절자인 알파-치환된 오메가-3 지질
Serhan Systems approach to inflammation resolution: identification of novel anti‐inflammatory and pro‐resolving mediators
EP2427415B1 (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
CN102256930B (zh) 作为抗痤疮剂的多不饱和脂肪酸及二醇酯
US8324264B1 (en) Inhibitors of bacterial biofilms and related methods
US9012505B2 (en) Antimicrobial compounds and uses thereof
US20120289596A1 (en) Dermatological Compositions Comprising a Fat or Oil of an Essential Fatty Acid Triglyceride
KR20080105095A (ko) 지질 유도체
JP2020514307A (ja) 化合物及び使用方法
PH12021550744A1 (en) Aromatic compounds and pharmaceutical uses thereof
HK1163655B (en) Polyunsaturated fatty acid and diol ester as an anti-acne agent
CN116898840A (zh) 抗微生物组合物、医药组合物及其用途
JP7168921B2 (ja) 脂肪酸組成物およびその製造方法、ならびに該脂肪酸組成物を含有する皮膚外用剤、医薬部外品および化粧品
DE4120916A1 (de) Omega-3 mehrfach ungesaettigte fettsaeurederivate, ihre herstellung und verwendung

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1163655

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1163655

Country of ref document: HK